15:10:16 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2023-02-24 Bokslutskommuniké 2022
2022-11-29 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning BRIG 0.00 SEK
2022-05-04 Kvartalsrapport 2022-Q1
2022-02-28 Bokslutskommuniké 2021
2021-12-07 Extra Bolagsstämma 2021
2021-11-15 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-06-17 Årsstämma 2021
2021-05-18 Ordinarie utdelning BRIG 0.00 SEK
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-26 Bokslutskommuniké 2020
2020-11-20 Extra Bolagsstämma 2020
2020-11-06 Kvartalsrapport 2020-Q3
2020-08-31 Kvartalsrapport 2020-Q2
2020-06-16 Ordinarie utdelning BRIG 0.00 SEK
2020-06-15 Årsstämma 2020
2020-04-30 Kvartalsrapport 2020-Q1
2020-02-27 Bokslutskommuniké 2019
2019-11-11 Extra Bolagsstämma 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-08-28 Kvartalsrapport 2019-Q2
2019-05-22 Kvartalsrapport 2019-Q1
2019-05-10 Ordinarie utdelning BRIG 0.00 SEK
2019-05-09 Årsstämma 2019
2019-02-27 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-24 Kvartalsrapport 2018-Q2
2018-05-17 Ordinarie utdelning BRIG 0.00 SEK
2018-05-16 Årsstämma 2018
2018-04-20 Kvartalsrapport 2018-Q1
2018-03-23 Bokslutskommuniké 2017
2017-11-24 Kvartalsrapport 2017-Q3
2017-09-29 Extra Bolagsstämma 2017
2017-08-25 Kvartalsrapport 2017-Q2
2017-06-12 Ordinarie utdelning BRIG 0.00 SEK
2017-06-09 Årsstämma 2017
2017-05-19 Kvartalsrapport 2017-Q1
2017-02-24 Bokslutskommuniké 2016
2016-11-25 Kvartalsrapport 2016-Q3
2016-08-26 Kvartalsrapport 2016-Q2
2016-05-20 Kvartalsrapport 2016-Q1
2016-05-18 Ordinarie utdelning BRIG 0.00 SEK
2016-05-17 Årsstämma 2016
2016-04-22 Ordinarie utdelning BRIG 0.00 SEK
2016-03-31 Bokslutskommuniké 2015
2015-12-11 Kvartalsrapport 2015-Q3
2015-08-28 Kvartalsrapport 2015-Q2
2015-06-15 Ordinarie utdelning BRIG 0.00 SEK
2015-06-12 Årsstämma 2015
2015-06-05 Kvartalsrapport 2015-Q1
2015-03-31 Bokslutskommuniké 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-15 Kvartalsrapport 2014-Q2
2014-06-19 Ordinarie utdelning BRIG 0.00 SEK
2014-06-18 Årsstämma 2014
2014-05-09 Kvartalsrapport 2014-Q1
2014-02-06 Bokslutskommuniké 2013
2013-11-14 Kvartalsrapport 2013-Q3
2013-08-15 Kvartalsrapport 2013-Q2
2013-05-23 Ordinarie utdelning BRIG 0.00 SEK
2013-05-22 Årsstämma 2013
2013-05-08 Kvartalsrapport 2013-Q1
2013-02-20 Bokslutskommuniké 2012
2012-12-05 15-7 2012
2012-11-14 Kvartalsrapport 2012-Q3
2012-08-31 Kvartalsrapport 2012-Q2
2012-06-21 Ordinarie utdelning BRIG 0.00 SEK
2012-06-20 Årsstämma 2012
2012-05-08 Kvartalsrapport 2012-Q1
2012-02-29 Bokslutskommuniké 2011

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Brighter är verksamt inom hälsoteknik- och välfärdssektorn genom ett flertal olika bolag och varumärken. Koncernen kommersialiserar produkter och tjänster med fokus på data-driven behandling av diabetes på distans samt erbjuder ett flertal digitala och fysiska lösningar för stöd och omsorg i hemmet. Huvudkontoret ligger i Stockholm och bolaget fokuserar huvudsakligen på Sverige, USA, Mellanöstern och Sydostasien.
2019-08-28 11:45:00

Petra Kaur, formerly Chief Communications and Marketing Officer, today assumes the role of Chief Commercial and Marketing Officer. The transition is a natural part of the company's ongoing change process, in which the need for commercialization and sales activities is increasing.

"Petra has long experience in sales and marketing in the pharmaceutical industry, combined with great understanding of Brighter's target group's needs. Now that the company is evolving and moving towards being more commercially active, we see it as a good time to implement this shift, meaning that Petra will have increased responsibility for Brighter's commercial business development," says Henrik Norström, Brighter's CEO.

Petra has worked at Brighter since 2014 and holds an MSc in Biology from Umeå University. She has a background in pharmacology at Karolinska Institutet, and also has long experience from a variety of leading roles in sales and marketing in companies within the pharmaceutical and health industry. These include AstraZeneca and Sanofi, as well as agencies like Nightingale, Ogilvy/INGO and Great Clearity.

"This new role means that I take on some of the sales and business development responsibilities that were Henrik's before he was appointed CEO. The company is undergoing change that requires both structural and process adjustments within the organization, as well as new hirings. I am very happy to be a part of Brighter at this exciting time and to continue to drive the company forward in my new role," says Petra Kaur.

"We see a growing need for healthtech solutions that facilitate and support behavioral change among patients. I will focus on developing and incorporating this thinking into all our current and future offerings," she says.

For further information, please contact:

Petra Kaur, Chief Commercial and Marketing Officer
Phone: +46 793 04 96 36   
E-mail: petra.kaur@brighter.se (henrik.norstrom@brighter.se) 

About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare's biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on NASDAQOMX First North/BRIG (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375). Brighter's Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 - 684 211 00, info@eminova.se, www.eminova.se.